A review by the new Trump administration and Congress of the 2010 Dodd-Frank legislation could address many of the stifling, unintended consequences of that law. Although designed to address abuses in the financial system that led to the 2008 recession, the far-reaching legislation had problems from the start. And while experts of all political stripes … Continue reading “Trump Administration Should Examine How Dodd-Frank Stifles Capital”
Category: San Diego
Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals
With the inauguration of Donald Trump as president on January 20th, the editors asked some of our Xconomists to offer their thoughts on “How could the incoming administration significantly affect your industry?” When I worked in the Reagan Administration, the “Gipper” used to handle questions like this by saying he couldn’t respond to hypothetical questions. … Continue reading “Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals”
AnaBios Receives $4,209,800 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4b8cc0fd-bb7b-4ae5-b525-06261f2484b8 Date 12/31/2016 Company Name AnaBios Mailing Address 3030 Bunker Hill Street San Diego, CA 92109 USA Company Description AnaBios preclinical drug discovery is entirely based on human-relevant data. Website http://www.anabios.com Transaction Type Venture Equity Transaction Amount $4,209,800 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “AnaBios Receives $4,209,800 Series B Funding Round”
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech
The idea that New York City could become a biotech powerhouse dates back to the late 1990s. It’s been a slow, tedious process, and it’s nowhere near complete, but from near and far, Harold Varmus and Vicki Sato have been watching the gears begin to turn. Varmus, who earned a Nobel prize for his work … Continue reading “Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech”
SD Venture Group Opens Bay Area Office as Part of “Cheeky” Campaign
The San Diego Venture Group has established a beachhead in San Francisco, and it’s opening for business Tuesday. After years of trying to persuade Silicon Valley venture capital firms to establish more of a presence in San Diego, or to at least hear more startup pitches here, the venture group has decided to open an … Continue reading “SD Venture Group Opens Bay Area Office as Part of “Cheeky” Campaign”
Despite Political Rhetoric, Staff Diversity Remains a Top Priority
I don’t think the election of Donald Trump as president does much to bolster those in tech working on creating a more inclusive and diverse industry, but I will continue to be a champion for it nonetheless. Specifically, I’ve ended 2016 by doubling our team at Localeur and introducing an Advisory Board, both of which … Continue reading “Despite Political Rhetoric, Staff Diversity Remains a Top Priority”
Political Focus on Rust Belt Could Help Boost VC Investment
Much has been written in the tech industry as a result of the Presidential election. Many coastal VCs and entrepreneurs believe that Trump’s America-first, anti-immigration platform could put the brakes on the venture industry’s core globalization strategies. While this may be true, regardless of which candidate you supported, most would agree that with chaos and … Continue reading “Political Focus on Rust Belt Could Help Boost VC Investment”
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug
[Updated, 12/29/16, see below] Patients with spinal muscular atrophy got some good news last week when the FDA approved nusinersen (Spinraza), making it the first marketed drug ever for the rare and potentially deadly genetic disease. But as expected, the drug, from Biogen and Ionis Pharmaceuticals, is a costly one, priced at the high end … Continue reading “Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug”
6 Cybersecurity Predictions for 2017: Ransomware, Skills Gap & More
In 2016, we saw cyber attacks increasingly shift from external breaches of confidential data to internal disruption of data and services, as attackers used distributed denial of service (DDoS) or encryption to hold businesses hostage. Attackers continue to focus more on exploiting users than technology. Users are often unaware and uneducated about the potential risks, … Continue reading “6 Cybersecurity Predictions for 2017: Ransomware, Skills Gap & More”
East Coast Silicon Valley
“You never change things by fighting the existing reality. To change something, build a new model that makes the existing model obsolete.” – R. Buckminster Fuller Reinvention A few months ago I was talking to executives in charge of innovation at a large U.S. bank. “Our biggest problem is that we look at all this new … Continue reading “East Coast Silicon Valley”
Immigration Restrictions, Lack of Healthcare Could Imperil Innovation
It’s hard to predict what effect the new administration will have, since we have very little information on any concrete policies they plan to enact. We do know a few things—namely, they are anti-Obamacare and anti-immigration. Decreasing the number of visas granted to highly skilled workers (a likely possibility given Steve Bannon’s comments on Silicon … Continue reading “Immigration Restrictions, Lack of Healthcare Could Imperil Innovation”
Opkix Receives $675,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a5ad6f81-7d39-4ea2-97a8-46eeb0d439e6 Date 12/26/2016 Company Name Opkix Mailing Address 1008 Brioso Drive Costa Mesa, CA 92627 USA Company Description Opkix’s first product is a small wearable 4K camera named, Opkix 1. Opkix creates products that challenge the conventional methods of how people capture and share videos. Opkix builds purpose-driven products that help create … Continue reading “Opkix Receives $675,000 Seed Funding Round”
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug
Patients with spinal muscular atrophy got an early Christmas present on Friday. The FDA approved nusinersen (Spinraza), making the drug the first-ever marketed treatment for the rare, potentially deadly genetic disorder. Nusinersen is an injectable drug developed by Ionis Pharmaceuticals (NASDAQ: [[ticker:IONS]]) and partner Biogen (NASDAQ: [[ticker:BIIB]]), and is meant to slow the progression of … Continue reading “Ionis, Biogen Make History With FDA Nod for Spine Disease Drug”
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More
You’ve probably seen the Internet memes. “When 2016 started, I looked like this. [Insert picture of young Leo DiCaprio.] Now I look like this. [Leo, with mountain beard, after mud-wrestling with a grizzly in The Revenant.]” In life science terms, let’s just say all our telomeres feel a lot shorter than 12 months ago. The … Continue reading “Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More”
The Price of Growth: Founders’ Dilution
Founders of a company considering the various available fundraising options often ask the challenging question: Why take venture capital money, which may significantly dilute the founders and might result in a loss of control of the company? Although the venture capital path is always a possibility, founders are often concerned about the consequences of such … Continue reading “The Price of Growth: Founders’ Dilution”
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)
We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here, with looks at key studies in lung cancer, Alzheimer’s disease, asthma, and more. In part two, we examine studies in leukemia, … Continue reading “14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)”
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)
[Updated, 4:28 pm ET, see below] After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical data—usually from big, late-stage studies—that can sometimes make or break a company. There were high profile successes in 2016. Biogen (NASDAQ: [[ticker:BIIB]]) and Ionis Pharmaceuticals (NASDAQ: … Continue reading “14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)”
Industry Needs Common Security Standards to Thwart IoT Attacks
A silver lining has emerged in the wake of the massive and well-publicized denial-of-service attack launched less than two months ago by hackers using millions of IoT devices to cripple the websites of major companies like Amazon, Netflix and Twitter. This ambush has triggered a redoubling of efforts to focus on the need for industry-led … Continue reading “Industry Needs Common Security Standards to Thwart IoT Attacks”
eSUB Construction Garners $5,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3a233af2-84c6-4384-bd18-079998319520 Date 12/21/2016 Company Name eSUB Construction Mailing Address 6048 Cornerstone Ct. West San Diego, CA 92121 USA Company Description Construction-Worker-Tablet_esubSubcontractors are an amazing bunch. When you look around, it’s incredible to gaze at the fabulous structures surrounding us, and to realize that it was Subcontractors who provided all the labor to … Continue reading “eSUB Construction Garners $5,000,000 Series A Financing Round”
Appetize Receives $20,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79d2c1ed-4805-44da-bf91-9472a95bf7ca Date 12/21/2016 Company Name Appetize Mailing Address 1601 Colorado Ave. Santa Monica, CA 90404 USA Company Description Appetize, the Los Angeles-based Point of Sale company, is serving its modern ordering and payment technology to over 400 enterprises today. Appetize is a fast growing and disruptive technology company that is steadily replacing … Continue reading “Appetize Receives $20,000,000 New Financing”
Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis
An Acadia Pharmaceuticals drug developed to treat hallucinations and delusions experienced by Parkinson’s disease patients is now showing signs it could also treat similar psychoses associated with Alzheimer’s disease. San Diego-based Acadia (NASDAQ: [[ticker:ACAD]]) reported that patients treated in an exploratory study with its drug pimavanserin showed a statistically significant reduction in psychosis compared against … Continue reading “Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis”
What Is Causing Startups to Go Bankrupt?
Many startups have a great product that’s viable, marketable, and ripe with potential. But if that was the only indicator of success, then nine out of 10 startups wouldn’t fail. The annals of startup history wouldn’t be littered with instances of companies like Friendster or Color that had fantastic products, but eventually sank. The truth … Continue reading “What Is Causing Startups to Go Bankrupt?”
7 Ways to Secure Your Connected Devices Against Hackers
’Tis the season for giving gifts. And increasingly, those shiny new toys and gadgets can be connected to the Internet—from TVs to watches, speakers to Barbie dolls. That Internet connection opens up a ton of possibilities for how we can use and enjoy our new devices. (“Alexa, play my Christmas playlist on Spotify, and also … Continue reading “7 Ways to Secure Your Connected Devices Against Hackers”
Grab Green Garners $2,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6405377d-0325-447b-a44b-533577fb7ad1 Date 12/19/2016 Company Name Grab Green Mailing Address 4620 Calle Quetzal Camarillo, CA 93012 USA Company Description Grab Green, the only eco-responsible brand innovating the Household Market by offering effective and healthier product collections that specifically connect with various consumer demographics. Website http://www.grabgreenhome.com Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction … Continue reading “Grab Green Garners $2,500,000 New Round”
LeaseLock Lands $1,000,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07c7a9f1-b6ea-4b29-8668-ebc3fa15af48 Date 12/19/2016 Company Name LeaseLock Mailing Address 1055 W 7th Street 33rd Floor Los Angeles, CA 90017 USA Company Description Commercial guarantor LeaseLock gives renters access to leasing units that are otherwise difficult to obtain without a co-signer or individual guarantor, and safely exposes landlords to a larger pool of prospective … Continue reading “LeaseLock Lands $1,000,000 Seed Funding Round”
OpenBazaar Obtains $3,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8cbe6a1-f874-406d-a116-3725f195c118 Date 12/17/2016 Company Name OpenBazaar Mailing Address Undisclosed San Diego, CA 92121 USA Company Description OpenBazaar is a new way to trade online. By running a program on your computer, you can connect directly to other users in the OpenBazaar network and trade with them. This network isn’t controlled by a … Continue reading “OpenBazaar Obtains $3,000,000 New Financing”
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More
The 21st Century Cures Act is now law. New York wants to play in the biotech big leagues. The FDA under Trump will have license to approve drugs faster and could have a former top official back on board as commissioner. An eye drug failed, an Alzheimer’s drug got scrutinized, and a new antibiotic passed … Continue reading “Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More”
BioIQ Receives $7,067,331 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=379beb28-919e-4f03-9880-a98d9f4b812d Date 12/16/2016 Company Name BioIQ Mailing Address 1222 State Street Santa Barbara, CA 93101 USA Company Description BioIQ is a health screening technology company that has developed a versatile technology platform to optimize health and save lives. Website http://www.bioiq.com Transaction Type Venture Equity Transaction Amount $7,067,331 Transaction Round Undisclosed Proceeds Purposes … Continue reading “BioIQ Receives $7,067,331 New Round”
Apeel Sciences Secures $33,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c3bf8760-4f86-430e-bbd1-01a913b684de Date 12/15/2016 Company Name Apeel Sciences Mailing Address 819 Reddick Street Santa Barbara, CA 93103 USA Company Description We use our natural plant-based technologies to protect crops and harvested produce, helping to eliminate food spoilage and reduce reliance on chemicals. Website http://www.apeelsciences.com Transaction Type Venture Equity Transaction Amount $33,000,000 Transaction Round … Continue reading “Apeel Sciences Secures $33,000,000 New Financing”
Survios Garners $50,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a4e6adb-2543-42bb-aa78-33ae5997dfb9 Date 12/15/2016 Company Name Survios Mailing Address 3249 S. La Cienega Blvd. Culver City, CA 90016 USA Company Description It all began with Project Holodeck, which was started back in March 2012 at a virtual reality conference in Orange County, CA, with Nathan Burba, James Iliff, and Palmer Luckey. Website http://www.survios.com … Continue reading “Survios Garners $50,000,000 New Funding Round”
50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them
If you’re not much of a podcast listener and you have a sense that you’re missing out on a lot of great content, you’re absolutely right. But now is a good time to fix that, thanks to a new profusion of listening options. And to get you started, I have a few shows to suggest. … Continue reading “50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them”
DermTech Lands $3,119,247 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da558eb0-5b7b-4d45-8909-acb271e013ec Date 12/14/2016 Company Name DermTech Mailing Address 11099 North Torrey Pines Road La Jolla, CA 92037 USA Company Description DermTech in La Jolla, CA develops qPCR assays and diagnostic aides for skin samples collected non-invasively to detect melanoma and skin cancer. Website http://www.dermtech.com Transaction Type Venture Equity Transaction Amount $3,119,247 Transaction … Continue reading “DermTech Lands $3,119,247 New Round”
Organovo Discloses First Preclinical Data on Human Liver “Patch”
After taking the first steps toward the development of living human liver tissue “patches” for therapeutic use, San Diego-based Organovo (NASDAQ: [[ticker:ONVO]]) is laying out its pre-clinical data for the first time today. And the company says the results are promising enough to warrant further development of the technology. Organovo CEO Keith Murphy said in … Continue reading “Organovo Discloses First Preclinical Data on Human Liver “Patch””
Molecular Assemblies Obtains $2,300,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a022d5d-dc54-4908-bbbf-0b876aa0094f Date 12/13/2016 Company Name Molecular Assemblies Mailing Address 10355 Science Center Dr. San Diego, CA 92121 USA Company Description The Molecular Assemblies story began more than 30 years ago when co-founders Dr. Bill Efcavitch and Curt Becker commercialized the first practical method of synthesizing DNA. Website http://www.molecularassemblies.com Transaction Type Venture Equity … Continue reading “Molecular Assemblies Obtains $2,300,000 Seed Funding”
ProLacta BioSciences Receives $34,999,997 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d37544cd-04ea-48e4-b7fb-1c702fce1334 Date 12/13/2016 Company Name ProLacta BioSciences Mailing Address 757 Baldwin Park Blvd. City of Industry, CA 91746 USA Company Description Prolacta Bioscience, headquartered in Monrovia, California is a life sciences company that provides specialty formulations of human milk for the immunological and nutritional needs of premature and critically ill infants. Website … Continue reading “ProLacta BioSciences Receives $34,999,997 New Funding Round”
San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis
Molecular Assemblies, a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round. The funding will be used to hire more scientists and to advance the company’s development of enzymatic DNA synthesis technology, CEO Michael Kamdar said in an interview Friday. Molecular … Continue reading “San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis”
Procore Technologies Garners $50,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c68f602-e2ff-428e-9dc2-be2411816804 Date 12/12/2016 Company Name Procore Technologies Mailing Address 6309 Carpinteria Ave. Carpinteria, CA 93013 USA Company Description Procore was founded in 2002 and provides contractors with software and services thatimprove the efficiency of construction projects. Procore’s web-based softwarecoordinates the project management activities of contractors, architects, and otherproject team members. Website http://www.pro-core.com … Continue reading “Procore Technologies Garners $50,000,000 New Round”
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”
When Eli Lilly (NYSE: [[ticker:LLY]]) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the disease, some observers immediately called it a final blow for the drug. After all, it had also failed to improve a broader range of patients with … Continue reading “Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song””
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More
What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to … Continue reading “Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More”
New Form Garners $18,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a95b01a4-c1ed-4e6d-9c64-3b33e11f2922 Date 12/9/2016 Company Name New Form Mailing Address Undisclosed Los Angeles, CA 90040 USA Company Description New Form is a new type of digital entertainment studio. Website http://www.newformdigital.com Transaction Type Venture Equity Transaction Amount $18,000,000 Transaction Round Undisclosed Proceeds Purposes The company said it will use the new funding — which … Continue reading “New Form Garners $18,000,000 New Round”
Crossover Health Lands $92,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eec5c7c3-1b29-468e-8a4d-5ccf78540f1c Date 12/9/2016 Company Name Crossover Health Mailing Address 65 Enterprise Aliso Viejo, CA 92656 USA Company Description Next Generation Health Care Website http://www.crossoverhealth.com Transaction Type Venture Equity Transaction Amount $92,000,000 Transaction Round Undisclosed Proceeds Purposes The funding is intended to increase the capital available for Crossover Health’s expansion and to buy … Continue reading “Crossover Health Lands $92,000,000 New Round”
Eversound Receives $3,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82eddd34-9327-4517-b5ab-ef5bcddb9a53 Date 12/9/2016 Company Name Eversound Mailing Address 1550 Pachino Circle Thousand Oaks, CA 91320 USA Company Description Our goal is to provide you, the listener, with the finest in new music. Website http://www.eversound.com Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round Undisclosed Proceeds Purposes Equipped with the latest round of … Continue reading “Eversound Receives $3,000,000 New Funding”
Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer
Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago. A health workup at his own high-end clinic, Health Nucleus, pinpointed the cancer. Famous for leading one of two teams in the 1990s that raced to unlock the human genome, Venter … Continue reading “Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer”
Gurnet Point Invests $92M in Crossover Health to Fund Growth
Cambridge, MA-based Gurnet Point Capital has invested $92 million in Crossover Health, a six-year-old company that provides membership-based healthcare services to employers that are self-insured. The funding is intended to increase the capital available for Crossover Health’s expansion and to buy out a portion of the company’s existing shareholders, the company said. The deal enables … Continue reading “Gurnet Point Invests $92M in Crossover Health to Fund Growth”
Wake Up, Pharma—Trump Is Not Your Savior
Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald Trump coming into office, the whole industry seems to have breathed a sigh of relief that the status quo—a continuous race toward higher prices—will last … Continue reading “Wake Up, Pharma—Trump Is Not Your Savior”
Fhoosh Receives $2,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c45c946-215f-4812-bd90-bfbd37387558 Date 12/8/2016 Company Name Fhoosh Mailing Address 7660 Fay Avenue La Jolla, CA 92037 USA Company Description Information security has always been central to our mission to protect and power data. We started FHOOSH because we were tired of filling out the same forms over and over. But we were also … Continue reading “Fhoosh Receives $2,000,000 New Financing Round”
Menlo Micro Obtains $18,700,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0476424e-52b0-4d41-b6b0-cc366b991b80 Date 12/8/2016 Company Name Menlo Micro Mailing Address 1 Technology Drive Irvine, CA 92618 USA Company Description Menlo Micro is reimagining one of the most fundamental building blocks of electronic systems – the electronic switch. The company’s Digital-Micro-Switch platform is a game changer for those who design electronic systems, with a … Continue reading “Menlo Micro Obtains $18,700,000 New Round”
Senate Approves 21st Century Cures Act, Sending Bill to Obama
The U.S. Senate has voted overwhelmingly to approve the 21st Century Cures Act, a wide-ranging healthcare spending and reform bill that aims to infuse medical research with new funding and also speed up the regulatory approval process for new drugs and medical devices. With the Senate’s 94-5 vote on Wednesday, the bill now advances to … Continue reading “Senate Approves 21st Century Cures Act, Sending Bill to Obama”
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial
[Corrected 3/1/17 to update trial data] Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo. Five of 38 adult leukemia patients taking the product in a clinical trial called “Rocket” have died from severe brain swelling caused by the treatment. In an after-dinner review at … Continue reading “At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial”
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More
Two years ago at the American Society of Hematology conference, excitement, not blood, was running in the streets of San Francisco. The cancer immunotherapy known as CAR-T was the star of the show, thanks to dazzling early data that showed more patients than not saw their leukemias and lymphomas knocked into remission by the living, … Continue reading “ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More”